LCN2 and oculocutaneous albinism type 1: In a subgroup analysis by thetype of AKI, the addition of NGAL improved prediction of 90-day survival inpatients with HRS and ATN, but not in the prerenal AKI or no AKI referencegroups (see Supplement Figure 3, Supplementary Digital Content 1, http://links.lww.com/CTG/A609).